SCHEMBL29098484

SCHEMBL29098484

O=C1CCC(N2C(=O)c3ccc(N4CCC(Oc5ccc(C(=O)O)cc5)CC4)cc3C2=O)C(=O)N1

nearest known ligand 0.65

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 19/20 0.65
▸ HPGDS O60760 2/20 0.52
▸ DDB1 Q16531 8/20 0.52
▸ AR P10275 6/20 0.51
▸ ALDH1A1 P00352 1/20 0.47
▸ CHRM2 P08172 1/20 0.47
▸ OPRM1 P35372 1/20 0.47
▸ IKZF3 Q9UKT9 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ BTK Q06187 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29546958 0.88 CRBN (0.54) CRBNHPGDSDDB1ARALDH1A1
SCHEMBL24379104 0.88 CRBN (0.54) CRBNHPGDSDDB1ARALDH1A1
SCHEMBL23129061 0.87 CRBN (0.65) CRBNHPGDSDDB1ARALDH1A1
SCHEMBL25216081 0.84 CRBN (0.69) CRBNHPGDSDDB1ARALDH1A1
SCHEMBL25201176 0.84 CRBN (0.65) CRBNHPGDSDDB1ARALDH1A1
SCHEMBL30441421 0.84 CRBN (0.65) CRBNHPGDSDDB1ARALDH1A1
SCHEMBL22692246 0.83 CRBN (0.53) CRBNHPGDSDDB1ARALDH1A1
SCHEMBL20046778 0.82 CRBN (0.56) CRBNHPGDSDDB1ARALDH1A1
SCHEMBL29223473 0.82 CRBN (0.69) CRBNHPGDSDDB1ARALDH1A1
SCHEMBL30692984 0.82 CRBN (0.62) CRBNHPGDSDDB1ALDH1A1CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4146660-A1 BIFUNCTIONAL DEGRADERS OF HEMATOPOIETIC PROGENITOR KINASE AND THERAPEUTIC USES THEREOF Nurix Therapeutics, Inc. (US) 2023-03-15 — — EP disclosed
CN-115605488-A Bifunctional degradants of hematopoietic progenitor kinases and therapeutic uses thereof 新锐思生物制药股份有限公司(US) 2023-01-13 — — CN disclosed
Send feedback